[Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
D000818:Animals; D001639:Bicarbonates; D001802:Blood Substitutes; D002122:Calcium Chloride; D004338:Drug Combinations; D005466:Fluorocarbons; D006324:Heart Arrest, Induced; D006895:Hydroxyethyl Starch Derivatives; D066298:In Vitro Techniques; D008274:Magnesium; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D011189:Potassium Chloride; D051381:Rats; D011919:Rats, Inbred Strains; D012965:Sodium Chloride
D001639:Bicarbonates; D001802:Blood Substitutes; D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C041711:St. Thomas' Hospital cardioplegic solution; D012965:Sodium Chloride; D011189:Potassium Chloride; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination; D008274:Magnesium; D002122:Calcium Chloride